REX Health Ventures is a venture capital firm that invests in healthcare companies.

REX Health Ventures

Rex Health Ventures (RHV) enables groundbreaking work by investing in and fostering companies and technologies that advance the future of health. As an entrepreneur-friendly strategic investor, RHV accelerates access to new healthcare products and services to improve patient care. RHV was established by UNC REX in 2012 as part of its commitment to innovation. Leveraging the talent and subject matter experts across UNC REX and the UNC Health network, RHV partners with emerging companies throughout North Carolina and the U.S.

Bardy Diagnostics

Veran Medical Technologies

Gauss Surgical

Phynd Technologies

Rex Health Ventures

Wonderful to see Censinet's recent release of the CPG Compliance Starter Toolkit, now available for American Hospital Association members.

This toolkit is like the Swiss Army knife of compliance towards the recently-announced goals – loaded with great tools to assess, align, benchmark, implement, monitor, and comply with Essential and Enhanced CPGs.

Grateful to the American Hospital Association for the collaboration and to Ed Gaudet and the Censinet team for all their effort in making this initiative happen. Thanks for all you do to continue making our healthcare ecosystem safer from cyberthreats.

Evan Bernath, Anita Watkins, John Perez, Rex Health Ventures

#HealthcareInnovation #Cybersecurity #Compliance

Big news from Arrivo BioVentures LLC! 
 
The FDA has granted Fast Track Designation to their novel lipase inhibitor, RABI-767, for the treatment of patients with acute pancreatitis at risk of progressing to severe disease.
 
“The Fast Track Designation highlights the high unmet medical need for patients with acute pancreatitis and the importance of finding safe, effective treatments,” said Steve Butts, CEO of Arrivo BioVentures.
 
Congratulations to Steve Butts and the entire Arrivo BioVentures team for this significant milestone. Rex Health Ventures is proud to support their innovative efforts in bringing life-saving solutions to patients facing this critical disease.
 
Anita Watkins, Evan Bernath, Natasha Bonett DeLong, John Perez, UNC Health
 
#Innovation #RexHealthVentures #FDAFastTrackDesignation #AcutePancreatitis #UNCHealth #CVC

Thank you for the great conversation with Giovanni Lauricella!  Rex Health Ventures, UNC Health, UNC Health Rex, MedTech World

We are thrilled to share the latest episode of the MedTech Startup Podcast featuring our very own Anita Watkins, Managing Director at Rex Health Ventures!
 
Anita sat down with Giovanni Lauricella, Managing Partner of Lifeblood, in Malta at MedTech World to discuss the pivotal role of UNC Health and hospital venture arms in MedTech innovation. Tune in to hear Anita’s insights on:
 
- Investment strategies for MedTech startups
- The unique advantages of partnering with hospital venture arms
- Significance of clinical data and early advocates
 
Thanks, Giovanni Lauricella, for hosting a great discussion. Don’t miss this deep dive into the world of healthcare system venture investing and reach out if you’d like to get more deeply connected with the Rex Health Ventures team.
 
https://lnkd.in/gRDwFXuG
 
John Perez, Evan Bernath, Natasha Bonett DeLong
 
#MedTech #Innovation #VentureCapital #Healthcare #CVC #RexHealthVentures

Let’s keep the good news rolling – congrats to Vergent Bioscience for this great validation! 

The Annals Of Thoracic Surgery has published Phase 2 data demonstrating that Vergent Bioscience’s tumor-targeted imaging agent, VGT-309, may help surgeons visualize difficult-to-find and previously undetected tumors during minimally invasive and robotic-assisted surgeries. 

Rex Health Ventures is proud of John Santini and the entire Vergent Bioscience team for their relentless innovation and dedication to improving patient lives. 

Anita Watkins, Evan Bernath, John Perez, UNC Health

#Innovation #RexHealthVentures #TumorVisualization #LungCancer #RoboticSurgery #SurgicalAdvancements #UNCHealth #CVC

💡 Applications for GRO are now open! 💡 

GRO is a 12-week Incubator powered by CED. 

If selected, you will attend weekly classes led by subject matter experts and seasoned entrepreneurs, where you will learn how to build a scalable business. Your company will be assigned a coach and you will receive 1:1 support, collaborate, and receive feedback as you progress.
 
Apply here ▶  https://lnkd.in/g_83FgE8

#GRO #entrepreneurship #startups

IPhone / Mobile Compatible

Viewport Meta

Apple Mobile Web Clips Icon

Google Font API

WordPress

Organization Schema

Sitelinks Search Box

Person Schema

Yoast WordPress SEO Plugin

Gravatar Profiles

Portfolio Manager

Natasha DeLong

Ray Jang

Senior Associate

Anita Watkins

Managing Director

Veran Medical Technologies is an image-guided medical device company that helps physicians diagnose disease and deliver therapies.

Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device .

Gauss Surgical is a med-tech company that develops a vision-based platform for accurate and real-time measurement of surgical blood loss.

Phynd Technologies is a provider of data management and provider search solutions.

Early Stage Venture Investors with Investments in St Louis, Missouri

Early Stage Venture Investors with Investments in Minnesota

Investors Active in Silicon Valley (Top 10K)

Investors Active in Southern US (Top 10K)

Rex Health Ventures (RHV) supports the discovery and development of new treatments, tools, products and services that foster innovation and positively impacts the provision of healthcare. They invest in and partner with companies and entrepreneurs to help bring their products and services into the healthcare marketplace.

news impact assignment basic	general
public peers	general	Aug 10, 2024 4:00 AM	68ab861a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 4, 2024 10:53 AM	b0b5cae6
crunchbase profile	general	Nov 4, 2024 11:33 AM	3fe111f7
li profile	general	Aug 10, 2024 4:00 AM	9d0cb63d
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	97f622fe
peers	general	Aug 10, 2024 4:00 AM	842a9f6a
news basic	general	Aug 10, 2024 4:00 AM	c6781f68
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

REXH

COM:REXHEALTHVENTURES

REX Health Ventures